Clinical Markers May Identify Patients at Risk for Early Parkinson’s Disease Dementia: A Prospective Study

1. Aarsland, D, Zaccai, J, Brayne, C. A systematic review of prevalence of dementia in Parkinson’s disease. Mov Disord. 2005;20(10):1255–1263.
Google Scholar | Crossref | Medline | ISI2. Hobson, P, Meara, J. Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in the United Kingdom. Mov Disord. 2004;19(9):1043–1049.
Google Scholar | Crossref | Medline3. Postuma, RB, Bertrand, JA, Montplaisir, J, et al. Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson’s disease: a prospective study. Mov Disord. 2012;27(6):720–726.
Google Scholar | Crossref | Medline | ISI4. Williams-Gray, CH, Foltynie, T, Brayne, CEG, Robbins, TW, Barker, RA. Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain. 2007;130(7):1787–1798.
Google Scholar | Crossref | Medline5. Baba, T, Kikuchi, A, Hirayama, K, et al. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson’s disease: a 3 year longitudinal study. Brain. 2012;135(1):161–169.
Google Scholar | Crossref | Medline6. Fereshtehnejad, S, Romenets, SR, Anang, JBM, Latreille, V, Gagnon, J-F, Postuma, RB. New clinical subtypes of Parkinson Disease and their longitudinal progression. A prospective cohort comparison with other phenotypes. JAMA Neurol. 2015;72(8):863–873.
Google Scholar | Crossref | Medline7. Hughes, AJ, Daniel, SE, Kilford, L, Lees, AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–184.
Google Scholar | Crossref | Medline | ISI8. Poewe, W, Gauthier, S, Aarsland, D, et al. Diagnosis and management of Parkinson’s disease dementia. Int J Clin Pract. 2008;62(10):1581–1587.
Google Scholar | Crossref | Medline9. Goetz, CG, Tilley, BC, Shaftman, SR, et al. Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–2170.
Google Scholar | Crossref | Medline | ISI10. Goetz, CG, Poewe, W, Rascol, O, et al. Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004;19(9):1020–1028.
Google Scholar | Crossref | Medline | ISI11. Wenning, GK, Tison, F, Seppi, K, et al. Development and validation of the unified multiple system. Mov Disord. 2004;19(12):1391–1402.
Google Scholar | Crossref | Medline12. Freeman, R, Weiling, W, Axelrod, F, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69–72.
Google Scholar | Crossref | Medline | ISI13. Bastien, CH, Vallieres, A, Morin, CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297–307.
Google Scholar | Crossref | Medline | ISI14. Folstein, MF, Folstein, SE, McHugh, PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
Google Scholar | Crossref | Medline | ISI15. Neuropsychiatric Inventory . Accessed April 19, 2011. www.npitest.net/about-npi.html
Google Scholar16. Hamilton Depression Rating Scale . Accessed March 21, 2011. www.psy-world.com/online_hamd.htm
Google Scholar17. Zimmermann, M, Martinez, JH, Young, D, Dalrymple, K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150(2):384–388.
Google Scholar | Crossref | Medline18. Girotti, F, Soliveri, P, Carella, F, et al. Dementia and cognitive impairment in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988;51(12):1498–1502.
Google Scholar | Crossref | Medline19. Starkstein, SE, Mayberg, HS, Leiguarda, R, Preziosi, TJ, Robinson, RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1992;55(5):377–382.
Google Scholar | Crossref | Medline | ISI20. Pilleri, M, Facchini, S, Gasparoli, E, et al. Cognitive and MRI correlates of orthostatic hypotension in Parkinson’s disease. J Neurol. 2013;260(1):253–259.
Google Scholar | Crossref | Medline21. Anang, JBM, Gagnon, JF, Bertrand, JA, et al. Predictors of dementia in Parkinson disease. A prospective cohort study. Neurology. 2014;83(14):1253–1260.
Google Scholar22. Mentis, A-F A, Dardiotis, E, Efthymiou, V, Chrousos, GP. Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews. BMC Med. 2021;19(1):6.
Google Scholar | Crossref | Medline23. Frewen, J, Finucane, C, Sawa, GM, Boyle, G, Kenny, RA. Orthostatic hypotension is associated with lower cognitive performance in adults aged 50 plus with supine hypertension. J Gerontol A Biol Sci Med Sci. 2013;69(7):878–885.
Google Scholar | Crossref | Medline24. Liu, H, Xing, A, Wang, X, Liu, G, Li, L. Regulation of beta-amyloid level in the brain of rats with cerebrovascular hypoperfusion. Neurobiol Aging. 2012;33(4):826. e31-42.
Google Scholar | Crossref | Medline25. de la Torre, JC . Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol. 2012;2012:367516.
Google Scholar | Crossref | Medline26. Freidenberg, DL, Shaffer, LE, Macalester, S, Fannin, EA. Orthostatic hypotension in patients with dementia: clinical features and response to treatment. Cogn Behav Neurol. 2013;26(3):105–120.
Google Scholar | Crossref | Medline27. Anderson, KN, Bradley, AJ. Sleep disturbance in mental health problems and neurodegenerative disease. Nat Sci Sleep. 2013;5:61–75.
Google Scholar | Crossref | Medline28. Alhola, P, Polo-Kantola, P. Sleep deprivation: Impact on cognitive performance. Neuropsychiatr Dis Treat. 2007;3(5):553–567.
Google Scholar | Medline29. Shi, L, Che, S-J, Ma, M-Y, et al. Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Med Rev. 2018;40:4–16.
Google Scholar | Crossref | Medline30. Foley, DJ, Monjan, AA, Brown, SL, Simonsick, EM, Wallace, RB, Blazer, DG. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep. 1995;18(6):425–432.
Google Scholar | Crossref | Medline | ISI31. Mazzoccoli, G, Vendemiale, G, La Viola, M, et al. Circadian variations of cortisol, melatonin and lymphocyte subpopulations in geriatric age. Int J Immunopathol Pharmacol. 2010;23(1):289–296.
Google Scholar | SAGE Journals | ISI32. Fulda, S . Idiopathic REM sleep behavior disorder as a long-term predictor of neurodegenerative disorders. EPMA. 2011;2(4):451–458.
Google Scholar | Crossref | Medline33. Mayberg, HS, Starkstein, SE, Sadzot, B, et al. Selective inferior frontal lobe hypometabolism in depressed patients with Parkinson’s disease. Ann Neurol. 1990;28(1):57–64.
Google Scholar | Crossref | Medline34. Molloy, SA, Rowan, EN, O’Brien, JT, McKeith, IG, Wesnes, K, Burn, DJ. Effect of levodopa on cognitive function in Parkinson’s disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006;77(12):1323–1328.
Google Scholar | Crossref | Medline35. Cools, R, Barker, RA, Sahakian, BJ, Robbins, TW. Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands. Cerebral Cortex. 2001;11(12):1136–1143.
Google Scholar | Crossref | Medline36. Stansley, BJ, Yamamoto, BK. L-dopa-induced dopamine synthesis and oxidative stress in serotoninergic cells. Neuropharmacology. 2013;67:243–251.
Google Scholar | Crossref | Medline37. Dettori, JR . Loss to follow-up. Evid Based Spine Care J. 2011;2(1):7–10.
Google Scholar | Crossref38. Maraki, MI, Stefanis, L, Yannakoulia, M, et al. Motor function and the probability of prodromal Parkinson’s disease in older adults. Mov Disord. 2019;34(9):1345–1353.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif